secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apogee Therapeutics, Inc. (APGE)
CIK:        0001974640
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0000950170-25-088600
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Apogee Therapeutics shareholders elect directors and ratify auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Elected Class II directors: Bollinger (35.1M for, 4.3M withheld), Kiselak (39.2M for), Shah (25.8M for, 13.6M withheld).
- Ratified Ernst & Young as independent auditor for FY2025 (41.2M for, 3K against).
- Advisory vote on say-on-pay frequency: 39.4M voted for one year; company will hold annual say-on-pay votes going forward.
- Broker non-votes of 1,795,017 on director elections and frequency vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1974640/000095017025088600/0000950170-25-088600-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1974640/000095017025088600/apge-20250617.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-088600

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer